Observational study on persistent allergic rhinitis patients to evaluate effectiveness of Dymista® nasal spray in daily practice

Study summary

No information provided.

Study identification

• EU PAS number:
  EUPAS22774
• Study ID:
  23063
• Official title and acronym:
  Observational study on persistent allergic rhinitis patients to evaluate effectiveness of Dymista® nasal spray in daily practice
• DARWIN EU® study:
  No
• Study countries:
  Austria

  Ireland

  Sweden
• Study description:
  The objective of this non-interventional study is gathering knowledge on effectiveness of Dymista® nasal spray in routine clinical practice in patients with Persistent Allergic Rhinitis assessed by means of a Visual Analogue Scale (VAS).
• Study status:
  Finalised

Research institutions and networks

Institutions

N/A

Study timelines

Date when funding contract was signed

Actual:30/09/2014

Study start date

Actual:01/11/2014

Date of final study report

Actual:16/12/2016

Sources of funding

Pharmaceutical company and other private sector 

More details on funding

MEDA Pharma GmbH & Co. KG

Regulatory

• Was the study required by a regulatory body?:
  No
• Is the study required by a Risk Management Plan (RMP)?:
  Not applicable